gene polymorphism
Article abstract-Migraine shows strong familial aggregation. However, the number of genes involved in the disorder is unknown and not identified. Nitric oxide is involved in the central processing of pain stimuli and plays an important role in the regulation of basal or stimulated vasodilation. Nitric oxide synthase, which controls the synthesis of nitric oxide, could possibly be a cause, or candidate gene, in migraine etiology .In this study, we detected a polymorphism for endothelial nitric oxide synthase by polymerase chain reaction and tested this for association and linkage to migraine. migraine, we performed association and linkage studies using a human endothelial NO synthase gene (NO83) polymorphism. We detected an NO83 highly polymorphic microsatellite marker by polymerase chain reaction (PCR) and tested it for linkage and association to migraine using large multigenerational pedigrees and migraine-affected and -unaffected populations.
Methods. Blood samples were collected from 91 migraine-affected and 85 unaffected individuals for the association studies and also from the members of 4 large multigenerational families for linkage studies. Prior to commencement, all research was approved by Griffith University's Ethics Committee for Experimentation on Humans. All individuals donating blood samples gave informed consent, and all were of Caucasian origin. Volunteers for the association studies and migraine pedigree index cases were recruited from subjects involved in the N ambour Skin Cancer Trial and also from individuals responding to national media release requests. For the association studies, individuals were classified as migraine-affected if they indicated by questionnaire that they had a family history of the disorder and that they themselves displayed symptoms consistent with migraine diagnosis according to International Headache Society (IHS) criteria.12 Similarly, control individuals indicated by questionnaire that they had no personal symptoms and no family history of the disorder. For the linkage studies, all family pedigree members were personally interviewed by a clinical neurologist to establish diagnosis following the criteria specified by IHS, with affected individuals classified as having migraine with aura (MA) or migraine without aura (MO). DNA was extracted with use of a standard salting-out procedure,13 and genotypes for the NOS3 polymorphism were determined by PCR with fluorescently labeled primers. The NOS3 (CA)n repeat was within intron 1311 and was detected with a PCR protocol that included 100 ng of DNA sample in a 50-fLL reaction using HEX-labeled NOS3 PCR products were loaded onto 2% agarose gels initially to determine PCR results, then microsatellite allele sizes were determined by fluorescent detection of the amplified DNA fragments using an ABI 373 Sequencer with Genescan analysis software. Results.
The NOS3 polymorphism detected alleles ranging in size from 134 to 190 bp. In both association and linkage studies, most individuals were typed as heterozygotes. Twenty alleles were detected for the association studies and 15 alleles from the four families used in linkage studies. Chi-square analysis showed no significant difference between the migraine-affected and -unaffected populations for the polymorphism, X2 = 24.78; p = 0.168 (table  1) . This was confirmed by Monte Carlo analysis14 with 10,000 simulations, X2 = 24.78 and p = 0.155. One allele (164 bp), however, did show a small significant difference between the two populations (X2 = 10.56; p = 0.001), but the numbers of this allele in both populations were very small.
Individuals from four migraine families (MFl, MF7, MF14, and MF15) were genotyped for the polymorphism as shown in the figure. Four migraine pedigrees comprised of 116 individuals, 52 of whom were affected, were used in the linkage studies. The power of these pedigrees was calculated with use of the SIMLINK2° program, which estimates the power of a proposed linkage study for a complex genetic trait. These calculations showed that, using only three of these migraine pedigrees (MFl, MF7, and MF14) and a four-allele system, there is 85% power to detect significant linkage (LOD score ~3) to a distance of 15 cM. Therefore, using a more informative marker such as the 20-allele NOS3 marker and using four pedigrees, we estimate that we have at least 90% power to detect linkage out to 20 cM.
Discussion.
From use of association studies and parametric and nonparametric forms of linkage analysis, our results do not support a role for endothelial nitric oxide synthase (eNOS) in migraine etiology . Association results showed no significant difference between migraine and nonmigraine subjects. One specific allele (164 bp) showed a small significant difference, most likely caused by low numbers in sample size, although further investigation with a larger sample may be more definitive.
The NOS3 marker detected 20 alleles in the association study, reducing the accuracy of normalized chi-square analysis. To overcome this problem, we used a Monte Carlo test,14 applying the data set over 10,000 simulations to test for significant differences. Neither form of analysis detected any overall significant difference between the tested populations. Since association studies only test single points and those regions of the genome in linkage disequilibrium with the tested marker, we also performed linkage studies, which test not only the marker but areas linked to the marker, to determine the involvement of eNOS in migraine.
Linkage results from four migraine pedigrees did not indicate probable linkage of eNOS with the disorder. Total LOD scores for the NOS3 polymorphism and migraine significantly excluded linkage between the loci up to 8.5 cM. Since migraine is possibly a heterogeneous disorder, large pedigrees with sufficient inform ation to individually confirm or refute linkage should be used for linkage studies. Results from all the pedigrees showed probable nonlinkage with MF14 showing individual significant nonlinkage at close distances. Nonparametric analysis supported the parametric results by also showing no significant linkage of eNOS in any of the four tested pedigrees. Hence, linkage data obtained from the NOS3 polymorphism did not indicate probable linkage of eNOS to migraine and significantly excluded close linkage of NOS3 to migraine in one large migraine pedigree. Although eNOS does not appear to be involved in migraine etiology, other genes involved in vasodilation and the central processing of pain may still play a role in this complex disorder . , 9
